English

bluebird bio, Inc.

EDGAR

BLUE Quarterly report (10-Q) · filed 2025-05-14

Annual consolidated revenue for 2024: about USD 83.8M, using the latest reported figures. The previous period, 2023, was about USD 29.07M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

38.7 million USD

2025 Q1 · USD

Exact inputs and evidence

Revenue: 38712000 USD Source

Operating margin

-63.56%

2025 Q1 · %

Exact inputs and evidence

Operating Income: -24607000 USD Source
Revenue: 38712000 USD Source

Operating cash flow

-43.4 million USD

2025 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -43400000 USD Source

Free cash flow

-44.3 million USD

2025 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -43400000 USD Source
Capital Expenditure: 859000 USD Source

Cash and cash equivalents: 78.7 million USD 2025-03-31 Source
Exact value

78744000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 9.79 million shares 2025-03-31 Source
Exact value

9790000 shares

Reported share-count change

-94.94% · -184 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

193583000 shares · 2024-03-31· Source
9790000 shares · 2025-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

104 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Revenue: 16101000 USD · 2024-04-01 – 2024-06-30 Source
Revenue: 10612000 USD · 2024-07-01 – 2024-09-30 Source
Revenue: 83795000 USD · 2024-01-01 – 2024-12-31 Source
Revenue: 45274000 USD · 2024-01-01 – 2024-09-30 Source
Revenue: 38712000 USD · 2025-01-01 – 2025-03-31 Source

Net income

-200 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Net income: -81393000 USD · 2024-04-01 – 2024-06-30 Source
Net income: -60808000 USD · 2024-07-01 – 2024-09-30 Source
Net income: -240715000 USD · 2024-01-01 – 2024-12-31 Source
Net income: -212000000 USD · 2024-01-01 – 2024-09-30 Source
Net income: -29100000 USD · 2025-01-01 – 2025-03-31 Source

Operating cash flow

-229 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Operating cash flow: -140900000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -74676000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -209900000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -140900000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -260000000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -209900000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -43400000 USD · 2025-01-01 – 2025-03-31 Source

Capital expenditure

1.68 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Capital expenditure: 1834000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 1775000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 2114000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 1834000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 2599000 USD · 2024-01-01 – 2024-12-31 Source
Capital expenditure: 2114000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 859000 USD · 2025-01-01 – 2025-03-31 Source

Free cash flow

-230 million USD

2024-04-01 – 2025-03-31

Exact inputs and evidence

Operating cash flow: -140900000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -74676000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -209900000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -140900000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -260000000 USD · 2024-01-01 – 2024-12-31 Source
Operating cash flow: -209900000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -43400000 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 1834000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 1775000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 2114000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 1834000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 2599000 USD · 2024-01-01 – 2024-12-31 Source
Capital expenditure: 2114000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 859000 USD · 2025-01-01 – 2025-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-05-14.

Financial data available through: 2024-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2024-12-31
Operating income: 11 of 11 periods available· newest 2024-12-31
Net income: 11 of 11 periods available· newest 2024-12-31
Operating cash flow: 11 of 11 periods available· newest 2024-12-31
Capital expenditure: 11 of 11 periods available· newest 2024-12-31
Total assets: 11 of 11 periods available· newest 2024-12-31
Total liabilities: 11 of 11 periods available· newest 2024-12-31
Current assets: 11 of 11 periods available· newest 2024-12-31
Current liabilities: 11 of 11 periods available· newest 2024-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+188.3%

Prior period

USD 29.07 million

2023-01-01 – 2023-12-31
Current period

USD 83.8 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

83795000 − 29065000 = 54730000 USD

29065000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
83795000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · bluebird bio, Inc. · 2024-12-31 bluebird bio, Inc. (edgar:1293971) Year-over-year change in Revenue: 54730000 USD Concept: fundies:Revenue Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 83795000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1695494 Filing: 000129397125000009 Input fundies:Revenue: 29065000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1696478 Filing: 000129397125000009
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 28.8 million

Prior period

−USD 211.91 million

2023-01-01 – 2023-12-31
Current period

−USD 240.72 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-240715000 − -211913000 = -28802000 USD

-211913000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-240715000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · bluebird bio, Inc. · 2024-12-31 bluebird bio, Inc. (edgar:1293971) Year-over-year change in Net income: -28802000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -240715000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1502440 Filing: 000129397125000009 Input fundies:NetIncome: -211913000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1503222 Filing: 000129397125000009
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 24.95 million

Prior period

−USD 235.05 million

2023-01-01 – 2023-12-31
Current period

−USD 260 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

-260000000 − -235046000 = -24954000 USD

-235046000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
-260000000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · bluebird bio, Inc. · 2024-12-31 bluebird bio, Inc. (edgar:1293971) Year-over-year change in Operating cash flow: -24954000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -260000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1592960 Filing: 000129397125000009 Input fundies:OperatingCashFlow: -235046000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1533806 Filing: 000129397125000009
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-38%

Prior period

USD 4.19 million

2023-01-01 – 2023-12-31
Current period

USD 2.6 million

2024-01-01 – 2024-12-31

Exact inputs and evidence

2599000 − 4189000 = -1590000 USD

4189000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source
2599000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · bluebird bio, Inc. · 2024-12-31 bluebird bio, Inc. (edgar:1293971) Year-over-year change in Capital expenditure: -1590000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2599000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1535195 Filing: 000129397125000009 Input fundies:CapitalExpenditure: 4189000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1535789 Filing: 000129397125000009
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

Revenue USD 83.8 million 100% of revenue
Cost of revenue USD 89.38 million 107% of revenue
Operating expenses USD 262.13 million 313% of revenue
Other operating costs Derived USD 2.75 million 3.3% of revenue
Operating income −USD 270.46 million −323% of revenue
Tax, interest and other Derived −USD 29.75 million −35% of revenue
Net income −USD 240.72 million −287% of revenue

Cash

Operating cash flow −USD 260 million −310% of revenue
Capital expenditure USD 2.6 million 3.1% of revenue
Free cash flow Derived −USD 262.6 million −313% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2015 Operating loss: operating costs were 1,301% of revenue.
2016 Operating loss: operating costs were 4,451% of revenue.
2017 Operating loss: operating costs were 1,038% of revenue.
2018 Operating loss: operating costs were 1,148% of revenue.
2019 Not shown: operating income or net income is not reported.
2020 Not shown: operating income or net income is not reported.
2021 Operating loss: operating costs were 16,236% of revenue.
2022 Operating loss: operating costs were 9,234% of revenue.
2023 Operating loss: operating costs were 940% of revenue.
2024 Operating loss: operating costs were 423% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2015 2015-01-01 – 2015-12-31	14079000	183116000 Derived	-169037000	-2254000 Derived	-166783000	-105484000 Derived	Source 2015-01-01 – 2015-12-31: 14079000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -169037000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -166783000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -98429000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 7055000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	6155000	273985000 Derived	-267830000	-4323000 Derived	-263507000	-217676000 Derived	Source 2016-01-01 – 2016-12-31: 6155000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -267830000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -263507000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -189647000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 28029000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	35427000	367592000 Derived	-332165000	3478000 Derived	-335643000	-342795000 Derived	Source 2017-01-01 – 2017-12-31: 35427000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -332165000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -335643000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -280553000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 62242000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	54579000	626602000 Derived	-572023000	-16398000 Derived	-555625000	-469163000 Derived	Source 2018-01-01 – 2018-12-31: 54579000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -572023000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -555625000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -413426000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 55737000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	0	562963000 Derived	-562963000	226645000 Derived	-789608000	-635412000 Derived	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -562963000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -789608000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -564384000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 71028000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	0	559259000 Derived	-559259000	59436000 Derived	-618695000	-499337000 Derived	Source 2020-01-01 – 2020-12-31: 0 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -559259000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -618695000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -470351000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 28986000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	3662000	594573000 Derived	-590911000	228467000 Derived	-819378000	-650142000 Derived	Source 2021-01-01 – 2021-12-31: 3662000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -590911000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -819378000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -635639000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 14503000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	2739000	252924000 Derived	-250185000	-19843000 Derived	-230342000	-324427000 Derived	Source 2022-01-01 – 2022-12-31: 2739000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -250185000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -230342000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -316219000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 8208000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	29065000	273327000 Derived	-244262000	-32349000 Derived	-211913000	-239235000 Derived	Source 2023-01-01 – 2023-12-31: 29065000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -244262000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -211913000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -235046000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 4189000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	83795000	354256000 Derived	-270461000	-29746000 Derived	-240715000	-262599000 Derived	Source 2024-01-01 – 2024-12-31: 83795000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -270461000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -240715000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -260000000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 2599000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 83.8M 2024

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	14079000	Revenue: 14079000 Open source
20162016-12-31	Revenue	6155000	Revenue: 6155000 Open source
20172017-12-31	Revenue	35427000	Revenue: 35427000 Open source
20182018-12-31	Revenue	54579000	Revenue: 54579000 Open source
20192019-12-31	Revenue	0	Revenue: 0 Open source
20202020-12-31	Revenue	0	Revenue: 0 Open source
20212021-12-31	Revenue	3662000	Revenue: 3662000 Open source
20222022-12-31	Revenue	2739000	Revenue: 2739000 Open source
20232023-12-31	Revenue	29065000	Revenue: 29065000 Open source
20242024-12-31	Revenue	83795000	Revenue: 83795000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

188.3% 2024

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	-44.6%	Revenue: 14079000 Open source Revenue: 25421000 Open source
20162016-12-31	Year over year	-56.3%	Revenue: 6155000 Open source Revenue: 14079000 Open source
20172017-12-31	Year over year	475.6%	Revenue: 35427000 Open source Revenue: 6155000 Open source
20182018-12-31	Year over year	54.1%	Revenue: 54579000 Open source Revenue: 35427000 Open source
20192019-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 54579000 Open source
20202020-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20212021-12-31	Year over year	No prior comparable period	Revenue: 3662000 Open source Revenue: 0 Open source
20222022-12-31	Year over year	-25.2%	Revenue: 2739000 Open source Revenue: 3662000 Open source
20232023-12-31	Year over year	961.2%	Revenue: 29065000 Open source Revenue: 2739000 Open source
20242024-12-31	Year over year	188.3%	Revenue: 83795000 Open source Revenue: 29065000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -322.8% 2024

Net margin -287.3% 2024

Free cash flow margin -313.4% 2024

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-1,200.6%	Operating Income: -169037000 Open source Revenue: 14079000 Open source
20162016-12-31	Operating margin	-4,351.4%	Operating Income: -267830000 Open source Revenue: 6155000 Open source
20172017-12-31	Operating margin	-937.6%	Operating Income: -332165000 Open source Revenue: 35427000 Open source
20182018-12-31	Operating margin	-1,048.1%	Operating Income: -572023000 Open source Revenue: 54579000 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -562963000 Open source Revenue: 0 Open source
20202020-12-31	Operating margin	Not reported	Operating Income: -559259000 Open source Revenue: 0 Open source
20212021-12-31	Operating margin	-16,136.3%	Operating Income: -590911000 Open source Revenue: 3662000 Open source
20222022-12-31	Operating margin	-9,134.2%	Operating Income: -250185000 Open source Revenue: 2739000 Open source
20232023-12-31	Operating margin	-840.4%	Operating Income: -244262000 Open source Revenue: 29065000 Open source
20242024-12-31	Operating margin	-322.8%	Operating Income: -270461000 Open source Revenue: 83795000 Open source
20152015-12-31	Net margin	-1,184.6%	Net Income: -166783000 Open source Revenue: 14079000 Open source
20162016-12-31	Net margin	-4,281.2%	Net Income: -263507000 Open source Revenue: 6155000 Open source
20172017-12-31	Net margin	-947.4%	Net Income: -335643000 Open source Revenue: 35427000 Open source
20182018-12-31	Net margin	-1,018%	Net Income: -555625000 Open source Revenue: 54579000 Open source
20192019-12-31	Net margin	Not reported	Net Income: -789608000 Open source Revenue: 0 Open source
20202020-12-31	Net margin	Not reported	Net Income: -618695000 Open source Revenue: 0 Open source
20212021-12-31	Net margin	-22,375.2%	Net Income: -819378000 Open source Revenue: 3662000 Open source
20222022-12-31	Net margin	-8,409.7%	Net Income: -230342000 Open source Revenue: 2739000 Open source
20232023-12-31	Net margin	-729.1%	Net Income: -211913000 Open source Revenue: 29065000 Open source
20242024-12-31	Net margin	-287.3%	Net Income: -240715000 Open source Revenue: 83795000 Open source
20152015-12-31	Free cash flow margin	-749.2%	Revenue: 14079000 Open source Operating Cash Flow: -98429000 Open source Capital Expenditure: 7055000 Open source
20162016-12-31	Free cash flow margin	-3,536.6%	Revenue: 6155000 Open source Operating Cash Flow: -189647000 Open source Capital Expenditure: 28029000 Open source
20172017-12-31	Free cash flow margin	-967.6%	Revenue: 35427000 Open source Operating Cash Flow: -280553000 Open source Capital Expenditure: 62242000 Open source
20182018-12-31	Free cash flow margin	-859.6%	Revenue: 54579000 Open source Operating Cash Flow: -413426000 Open source Capital Expenditure: 55737000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -564384000 Open source Capital Expenditure: 71028000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -470351000 Open source Capital Expenditure: 28986000 Open source
20212021-12-31	Free cash flow margin	-17,753.7%	Revenue: 3662000 Open source Operating Cash Flow: -635639000 Open source Capital Expenditure: 14503000 Open source
20222022-12-31	Free cash flow margin	-11,844.7%	Revenue: 2739000 Open source Operating Cash Flow: -316219000 Open source Capital Expenditure: 8208000 Open source
20232023-12-31	Free cash flow margin	-823.1%	Revenue: 29065000 Open source Operating Cash Flow: -235046000 Open source Capital Expenditure: 4189000 Open source
20242024-12-31	Free cash flow margin	-313.4%	Revenue: 83795000 Open source Operating Cash Flow: -260000000 Open source Capital Expenditure: 2599000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -260M 2024

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	-98429000	Operating Cash Flow: -98429000 Open source
20162016-12-31	Operating cash flow	-189647000	Operating Cash Flow: -189647000 Open source
20172017-12-31	Operating cash flow	-280553000	Operating Cash Flow: -280553000 Open source
20182018-12-31	Operating cash flow	-413426000	Operating Cash Flow: -413426000 Open source
20192019-12-31	Operating cash flow	-564384000	Operating Cash Flow: -564384000 Open source
20202020-12-31	Operating cash flow	-470351000	Operating Cash Flow: -470351000 Open source
20212021-12-31	Operating cash flow	-635639000	Operating Cash Flow: -635639000 Open source
20222022-12-31	Operating cash flow	-316219000	Operating Cash Flow: -316219000 Open source
20232023-12-31	Operating cash flow	-235046000	Operating Cash Flow: -235046000 Open source
20242024-12-31	Operating cash flow	-260000000	Operating Cash Flow: -260000000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -262.6M 2024

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	-105484000	Operating Cash Flow: -98429000 Open source Capital Expenditure: 7055000 Open source
20162016-12-31	Free cash flow	-217676000	Operating Cash Flow: -189647000 Open source Capital Expenditure: 28029000 Open source
20172017-12-31	Free cash flow	-342795000	Operating Cash Flow: -280553000 Open source Capital Expenditure: 62242000 Open source
20182018-12-31	Free cash flow	-469163000	Operating Cash Flow: -413426000 Open source Capital Expenditure: 55737000 Open source
20192019-12-31	Free cash flow	-635412000	Operating Cash Flow: -564384000 Open source Capital Expenditure: 71028000 Open source
20202020-12-31	Free cash flow	-499337000	Operating Cash Flow: -470351000 Open source Capital Expenditure: 28986000 Open source
20212021-12-31	Free cash flow	-650142000	Operating Cash Flow: -635639000 Open source Capital Expenditure: 14503000 Open source
20222022-12-31	Free cash flow	-324427000	Operating Cash Flow: -316219000 Open source Capital Expenditure: 8208000 Open source
20232023-12-31	Free cash flow	-239235000	Operating Cash Flow: -235046000 Open source Capital Expenditure: 4189000 Open source
20242024-12-31	Free cash flow	-262599000	Operating Cash Flow: -260000000 Open source Capital Expenditure: 2599000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

106.9% 2024

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	15.1%	Total Liabilities: 151841000 Open source Total Assets: 1002337000 Open source
20162016-12-31	Liabilities / assets	22.2%	Total Liabilities: 248682000 Open source Total Assets: 1118122000 Open source
20172017-12-31	Liabilities / assets	14.6%	Total Liabilities: 277135000 Open source Total Assets: 1900567000 Open source
20182018-12-31	Liabilities / assets	16%	Total Liabilities: 357774000 Open source Total Assets: 2242844000 Open source
20192019-12-31	Liabilities / assets	25.6%	Total Liabilities: 442431000 Open source Total Assets: 1727424000 Open source
20202020-12-31	Liabilities / assets	23.9%	Total Liabilities: 426196000 Open source Total Assets: 1781252000 Open source
20212021-12-31	Liabilities / assets	37%	Total Liabilities: 219518000 Open source Total Assets: 593795000 Open source
20222022-12-31	Liabilities / assets	76.4%	Total Liabilities: 435481000 Open source Total Assets: 569814000 Open source
20232023-12-31	Liabilities / assets	68.6%	Total Liabilities: 424624000 Open source Total Assets: 619161000 Open source
20242024-12-31	Liabilities / assets	106.9%	Total Liabilities: 491766000 Open source Total Assets: 460232000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.48× 2024

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	12.98×	Current Assets: 523965000 Open source Current Liabilities: 40368000 Open source
20162016-12-31	Current assets / current liabilities	9.72×	Current Assets: 724214000 Open source Current Liabilities: 74533000 Open source
20172017-12-31	Current assets / current liabilities	13.83×	Current Assets: 1322769000 Open source Current Liabilities: 95612000 Open source
20182018-12-31	Current assets / current liabilities	9.69×	Current Assets: 1418997000 Open source Current Liabilities: 146431000 Open source
20192019-12-31	Current assets / current liabilities	5.15×	Current Assets: 1152174000 Open source Current Liabilities: 223580000 Open source
20202020-12-31	Current assets / current liabilities	5.97×	Current Assets: 1215537000 Open source Current Liabilities: 203588000 Open source
20212021-12-31	Current assets / current liabilities	2.2×	Current Assets: 336520000 Open source Current Liabilities: 152993000 Open source
20222022-12-31	Current assets / current liabilities	1.3×	Current Assets: 203572000 Open source Current Liabilities: 156579000 Open source
20232023-12-31	Current assets / current liabilities	1.41×	Current Assets: 281685000 Open source Current Liabilities: 200113000 Open source
20242024-12-31	Current assets / current liabilities	0.48×	Current Assets: 154668000 Open source Current Liabilities: 321462000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	−USD 166.78 million Exact value Exact value: -166783000 USD 2015-01-01 – 2015-12-31: -166783000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2015-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -166783000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -166783000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459018002704/blue-20171231.xml#184872 Filing: 000156459018002704 The citation records this snapshot. The page link may show a newer release later.	−USD 98.43 million Exact value Exact value: -98429000 USD 2015-01-01 – 2015-12-31: -98429000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2015-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -98429000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -98429000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459018002704/blue-20171231.xml#219889 Filing: 000156459018002704 The citation records this snapshot. The page link may show a newer release later.	USD 7.06 million Exact value Exact value: 7055000 USD 2015-01-01 – 2015-12-31: 7055000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2015-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 7055000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7055000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459017002015/blue-20161231.xml#180127 Filing: 000156459017002015 The citation records this snapshot. The page link may show a newer release later.	−USD 105.48 million Calculation and evidence -98429000 − 7055000 USD Exact free cash flow: -105484000 USD 2015-01-01 – 2015-12-31: -98429000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 7055000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2015-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -105484000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -98429000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459018002704/blue-20171231.xml#219889 Filing: 000156459018002704 Input fundies:CapitalExpenditure: 7055000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459017002015/blue-20161231.xml#180127 Filing: 000156459017002015 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 263.51 million Exact value Exact value: -263507000 USD 2016-01-01 – 2016-12-31: -263507000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2016-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -263507000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -263507000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459019003694/blue-20181231.xml#215871 Filing: 000156459019003694 The citation records this snapshot. The page link may show a newer release later.	−USD 189.65 million Exact value Exact value: -189647000 USD 2016-01-01 – 2016-12-31: -189647000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2016-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -189647000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -189647000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459019003694/blue-20181231.xml#252124 Filing: 000156459019003694 The citation records this snapshot. The page link may show a newer release later.	USD 28.03 million Exact value Exact value: 28029000 USD 2016-01-01 – 2016-12-31: 28029000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2016-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 28029000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28029000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459019003694/blue-20181231.xml#252759 Filing: 000156459019003694 The citation records this snapshot. The page link may show a newer release later.	−USD 217.68 million Calculation and evidence -189647000 − 28029000 USD Exact free cash flow: -217676000 USD 2016-01-01 – 2016-12-31: -189647000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 28029000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2016-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -217676000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -189647000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459019003694/blue-20181231.xml#252124 Filing: 000156459019003694 Input fundies:CapitalExpenditure: 28029000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000156459019003694/blue-20181231.xml#252759 Filing: 000156459019003694 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 335.64 million Exact value Exact value: -335643000 USD 2017-01-01 – 2017-12-31: -335643000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2017-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -335643000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -335643000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397120000007/blue-20191231.htm#1923696 Filing: 000129397120000007 The citation records this snapshot. The page link may show a newer release later.	−USD 280.55 million Exact value Exact value: -280553000 USD 2017-01-01 – 2017-12-31: -280553000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2017-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -280553000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -280553000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397120000007/blue-20191231.htm#2136041 Filing: 000129397120000007 The citation records this snapshot. The page link may show a newer release later.	USD 62.24 million Exact value Exact value: 62242000 USD 2017-01-01 – 2017-12-31: 62242000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2017-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 62242000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 62242000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397120000007/blue-20191231.htm#2141926 Filing: 000129397120000007 The citation records this snapshot. The page link may show a newer release later.	−USD 342.8 million Calculation and evidence -280553000 − 62242000 USD Exact free cash flow: -342795000 USD 2017-01-01 – 2017-12-31: -280553000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 62242000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2017-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -342795000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -280553000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397120000007/blue-20191231.htm#2136041 Filing: 000129397120000007 Input fundies:CapitalExpenditure: 62242000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397120000007/blue-20191231.htm#2141926 Filing: 000129397120000007 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 555.63 million Exact value Exact value: -555625000 USD 2018-01-01 – 2018-12-31: -555625000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2018-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -555625000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -555625000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397121000013/blue-20201231.htm#1604654 Filing: 000129397121000013 The citation records this snapshot. The page link may show a newer release later.	−USD 413.43 million Exact value Exact value: -413426000 USD 2018-01-01 – 2018-12-31: -413426000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2018-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -413426000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -413426000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397121000013/blue-20201231.htm#1647645 Filing: 000129397121000013 The citation records this snapshot. The page link may show a newer release later.	USD 55.74 million Exact value Exact value: 55737000 USD 2018-01-01 – 2018-12-31: 55737000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2018-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 55737000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 55737000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397121000013/blue-20201231.htm#1651585 Filing: 000129397121000013 The citation records this snapshot. The page link may show a newer release later.	−USD 469.16 million Calculation and evidence -413426000 − 55737000 USD Exact free cash flow: -469163000 USD 2018-01-01 – 2018-12-31: -413426000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 55737000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2018-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -469163000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -413426000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397121000013/blue-20201231.htm#1647645 Filing: 000129397121000013 Input fundies:CapitalExpenditure: 55737000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397121000013/blue-20201231.htm#1651585 Filing: 000129397121000013 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 789.61 million Exact value Exact value: -789608000 USD 2019-01-01 – 2019-12-31: -789608000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2019-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -789608000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -789608000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397122000016/blue-20211231.htm#1349293 Filing: 000129397122000016 The citation records this snapshot. The page link may show a newer release later.	−USD 564.38 million Exact value Exact value: -564384000 USD 2019-01-01 – 2019-12-31: -564384000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2019-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -564384000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -564384000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397122000016/blue-20211231.htm#1395815 Filing: 000129397122000016 The citation records this snapshot. The page link may show a newer release later.	USD 71.03 million Exact value Exact value: 71028000 USD 2019-01-01 – 2019-12-31: 71028000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2019-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 71028000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 71028000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397122000016/blue-20211231.htm#1399776 Filing: 000129397122000016 The citation records this snapshot. The page link may show a newer release later.	−USD 635.41 million Calculation and evidence -564384000 − 71028000 USD Exact free cash flow: -635412000 USD 2019-01-01 – 2019-12-31: -564384000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 71028000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2019-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -635412000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -564384000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397122000016/blue-20211231.htm#1395815 Filing: 000129397122000016 Input fundies:CapitalExpenditure: 71028000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397122000016/blue-20211231.htm#1399776 Filing: 000129397122000016 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 618.7 million Exact value Exact value: -618695000 USD 2020-01-01 – 2020-12-31: -618695000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2020-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -618695000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -618695000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1325142 Filing: 000129397123000007 The citation records this snapshot. The page link may show a newer release later.	−USD 470.35 million Exact value Exact value: -470351000 USD 2020-01-01 – 2020-12-31: -470351000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2020-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -470351000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -470351000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1359223 Filing: 000129397123000007 The citation records this snapshot. The page link may show a newer release later.	USD 28.99 million Exact value Exact value: 28986000 USD 2020-01-01 – 2020-12-31: 28986000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2020-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 28986000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28986000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1362172 Filing: 000129397123000007 The citation records this snapshot. The page link may show a newer release later.	−USD 499.34 million Calculation and evidence -470351000 − 28986000 USD Exact free cash flow: -499337000 USD 2020-01-01 – 2020-12-31: -470351000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 28986000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2020-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -499337000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -470351000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1359223 Filing: 000129397123000007 Input fundies:CapitalExpenditure: 28986000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1362172 Filing: 000129397123000007 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 819.38 million Exact value Exact value: -819378000 USD 2021-01-01 – 2021-12-31: -819378000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2021-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -819378000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -819378000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1324303 Filing: 000129397123000007 The citation records this snapshot. The page link may show a newer release later.	−USD 635.64 million Exact value Exact value: -635639000 USD 2021-01-01 – 2021-12-31: -635639000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2021-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -635639000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -635639000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1358503 Filing: 000129397123000007 The citation records this snapshot. The page link may show a newer release later.	USD 14.5 million Exact value Exact value: 14503000 USD 2021-01-01 – 2021-12-31: 14503000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2021-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 14503000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14503000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1361520 Filing: 000129397123000007 The citation records this snapshot. The page link may show a newer release later.	−USD 650.14 million Calculation and evidence -635639000 − 14503000 USD Exact free cash flow: -650142000 USD 2021-01-01 – 2021-12-31: -635639000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 14503000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2021-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -650142000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -635639000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1358503 Filing: 000129397123000007 Input fundies:CapitalExpenditure: 14503000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397123000007/blue-20221231.htm#1361520 Filing: 000129397123000007 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 230.34 million Exact value Exact value: -230342000 USD 2022-01-01 – 2022-12-31: -230342000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2022-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -230342000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -230342000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397124000037/blue-20231231.htm#2082828 Filing: 000129397124000037 The citation records this snapshot. The page link may show a newer release later.	−USD 316.22 million Exact value Exact value: -316219000 USD 2022-01-01 – 2022-12-31: -316219000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2022-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -316219000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -316219000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397124000037/blue-20231231.htm#2125795 Filing: 000129397124000037 The citation records this snapshot. The page link may show a newer release later.	USD 8.21 million Exact value Exact value: 8208000 USD 2022-01-01 – 2022-12-31: 8208000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2022-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 8208000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8208000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397124000037/blue-20231231.htm#2128901 Filing: 000129397124000037 The citation records this snapshot. The page link may show a newer release later.	−USD 324.43 million Calculation and evidence -316219000 − 8208000 USD Exact free cash flow: -324427000 USD 2022-01-01 – 2022-12-31: -316219000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 8208000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2022-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -324427000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -316219000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397124000037/blue-20231231.htm#2125795 Filing: 000129397124000037 Input fundies:CapitalExpenditure: 8208000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397124000037/blue-20231231.htm#2128901 Filing: 000129397124000037 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 211.91 million Exact value Exact value: -211913000 USD 2023-01-01 – 2023-12-31: -211913000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2023-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -211913000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -211913000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1503222 Filing: 000129397125000009 The citation records this snapshot. The page link may show a newer release later.	−USD 235.05 million Exact value Exact value: -235046000 USD 2023-01-01 – 2023-12-31: -235046000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2023-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -235046000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -235046000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1533806 Filing: 000129397125000009 The citation records this snapshot. The page link may show a newer release later.	USD 4.19 million Exact value Exact value: 4189000 USD 2023-01-01 – 2023-12-31: 4189000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2023-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 4189000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4189000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1535789 Filing: 000129397125000009 The citation records this snapshot. The page link may show a newer release later.	−USD 239.24 million Calculation and evidence -235046000 − 4189000 USD Exact free cash flow: -239235000 USD 2023-01-01 – 2023-12-31: -235046000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 4189000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2023-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -239235000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -235046000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1533806 Filing: 000129397125000009 Input fundies:CapitalExpenditure: 4189000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1535789 Filing: 000129397125000009 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 240.72 million Exact value Exact value: -240715000 USD 2024-01-01 – 2024-12-31: -240715000 USD Inspect Net Income Open source Share or cite Citation for Net Income · bluebird bio, Inc. · 2024-12-31 bluebird bio, Inc. (edgar:1293971) Net Income: -240715000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -240715000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1502440 Filing: 000129397125000009 The citation records this snapshot. The page link may show a newer release later.	−USD 260 million Exact value Exact value: -260000000 USD 2024-01-01 – 2024-12-31: -260000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · bluebird bio, Inc. · 2024-12-31 bluebird bio, Inc. (edgar:1293971) Operating Cash Flow: -260000000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -260000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1592960 Filing: 000129397125000009 The citation records this snapshot. The page link may show a newer release later.	USD 2.6 million Exact value Exact value: 2599000 USD 2024-01-01 – 2024-12-31: 2599000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · bluebird bio, Inc. · 2024-12-31 bluebird bio, Inc. (edgar:1293971) Capital Expenditure: 2599000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2599000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1535195 Filing: 000129397125000009 The citation records this snapshot. The page link may show a newer release later.	−USD 262.6 million Calculation and evidence -260000000 − 2599000 USD Exact free cash flow: -262599000 USD 2024-01-01 – 2024-12-31: -260000000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 2599000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · bluebird bio, Inc. · 2024-12-31 bluebird bio, Inc. (edgar:1293971) Free cash flow: -262599000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T10:56:50Z Snapshot: 1955d0d888bcc6e159563964ffc132c5f4d4f1591425340ae66002f6d0014759 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1293971?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -260000000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1592960 Filing: 000129397125000009 Input fundies:CapitalExpenditure: 2599000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1293971/000129397125000009/blue-20241231.htm#1535195 Filing: 000129397125000009 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

66 filings · 3,638 latest values · 3,669 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001293971, 1293971, BLUE, edgar:1293971

Also known as Genetix Pharmaceuticals Inc, bluebird bio, Inc.

bluebird bio, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2024 2024-01-01 – 2024-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation